Insulin/IGF signaling-related gene expression in the Brain of a Sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin

Journal of Alzheimer's Disease

Volumn 38, Issue 2, 2014, Pages 251-267

  Lee, Youngjeon ^a   Kim, Young Hyun ^a   Park, Sang Je ^a   Huh, Jae Won ^a   Kim, Sang Hyun ^a   Kim, Sun Uk ^a   Kim, Ji Su ^a   Jeong, Kang Jin ^a   Lee, Kyoung Min ^b   Hong, Yonggeun ^c   Lee, Sang Rae ^a   Chang, Kyu Tae ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Inje University   (South Korea)

Author keywords

Alzheimer's disease; brain; insulin; monkey; real time quantitative polymerase chain reaction; streptozotocin

Indexed keywords

FLUORODEOXYGLUCOSE; GENOMIC DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; RIBOSOME PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN REGION; CELL TYPE; CISTERNA MAGNA; CONTROLLED STUDY; DOWN REGULATION; DURA MATER; EXON; FEMALE; FRONTAL CORTEX; GENE SEQUENCE; GLUCOSE METABOLISM; HIPPOCAMPUS; HOUSEKEEPING GENE; MACACA FASCICULARIS; MOLECULAR CLONING; MONKEY MODEL; NONHUMAN; OCCIPITAL CORTEX; OLIGODENDROGLIA; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

ALZHEIMER'S DISEASE; BRAIN; INSULIN; MONKEY; REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION; STREPTOZOTOCIN;

ALZHEIMER DISEASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; INJECTIONS, INTRAVENTRICULAR; INSULIN; MACACA FASCICULARIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOMATOMEDINS; STREPTOZOCIN; TIME FACTORS;

EID: 84889607139     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130776     Document Type: Article

References (59)

1. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
2. Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR (2009) An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J Alzheimers Dis 16, 741-761.
3. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C, Medical Research Council Cognitive F, Ageing S (2009) Age, neuropathology, and dementia. N Engl J Med 360, 2302-2309.
4. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222.
5. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225, 54-62.
6. Mistur R, Mosconi L, Santi SD, Guzman M, Li Y, TsuiW, de Leon MJ (2009) Current challenges for the early detection of Alzheimer's disease: Brain imaging and CSF studies. J Clin Neurol 5, 153-166.
7. de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease. J Alzheimers Dis 7, 45-61. (Pubitemid 40387184)
8. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes J Alzheimers Dis 7, 63-80. (Pubitemid 40387185)
9. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease Ageing Res Rev 10, 264-273.
10. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9, 13-33.
11. Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993) The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22, 1-10.
12. Zhao WQ, Chen H, Quon MJ, Alkon DL (2004) Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 490, 71-81. (Pubitemid 38482161)
13. Cardoso S, Correia S, Santos RX, Carvalho C, Santos MS, Oliveira CR, Perry G, Smith MA, Zhu X, Moreira PI (2009) Insulin is a two-edged knife on the brain. J Alzheimers Dis 18, 483-507.
14. Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: An experimental approach. J Neural Transm Suppl, 217-233.
15. Salkovic-Petrisic M, Osmanovic J, Grunblatt E, Riederer P, Hoyer S (2009) Modeling sporadic Alzheimer's disease: The insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J Alzheimers Dis 18, 729-750.
16. Heo JH, Lee SR, Lee ST, Lee KM, Oh JH, Jang DP, Chang KT, Cho ZH (2011) Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys. J Alzheimers Dis 25, 517-523.
17. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132, 365-386.
18. Huh JW, Kim YH, Park SJ, Kim DS, Lee SR, Kim KM, Jeong KJ, Kim JS, Song BS, Sim BW, Kim SU, Kim SH, Chang KT (2012) Large-scale transcriptome sequencing and gene analyses in the crab-eating macaque (Macaca fascicularis) for biomedical research. BMC Genomics 13, 163.
19. Park SJ, Kim YH, Lee Y, Kim KM, Kim HS, Lee SR, Kim SU, Kim SH, Kim JS, Jeong KJ, Lee KM, Huh JW, Chang KT (2013) Selection of appropriate reference genes for RT-qPCR analysis in a streptozotocin-induced Alzheimer's disease model of cynomolgus monkeys (Macaca fascicularis). PLoS One 8, e56034.
20. Hodgdon KE, Hingtgen CM, Nicol GD (2012) Dorsal root ganglia isolated from Nf1+/-mice exhibit increased levels of mRNA expression of voltage-dependent sodium channels. Neuroscience 206, 237-244.
21. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30, e36.
22. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101-1108. (Pubitemid 351818697)
23. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine. J Alzheimers Dis 8, 247-268.
24. Szabo A, Dalmau J, ManleyG, Rosenfeld M,Wong E, Henson J, Posner JB, Furneaux HM (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67, 325-333. (Pubitemid 121001448)
25. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.
26. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, Blitzer RD, AlberiniCM(2011) A critical role for IGF-II in memory consolidation and enhancement. Nature 469, 491-497.
27. Carson MJ, Behringer RR, Brinster RL, McMorris FA (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10, 729-740. (Pubitemid 23127975)
28. Guthrie KM, Nguyen T, Gall CM (1995) Insulin-like growth factor-1 mRNA is increased in deafferented hippocampus: Spatiotemporal correspondence of a trophic event with axon sprouting. J Comp Neurol 352, 147-160.
29. Dore S, Kar S, Quirion R (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against betaamyloid-and human amylin-induced toxicity. Proc Natl Acad Sci USA 94, 4772-4777. (Pubitemid 27194319)
30. Schechter R, AbboudM(2001) Neuronal synthesized insulin roles on neural differentiation within fetal rat neuron cell cultures. Brain Res Dev Brain Res 127, 41-49. (Pubitemid 32245736)
31. Schechter R, Beju D, GaffneyT, Schaefer F, WhetsellL(1996) Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system. Brain Res 736, 16-27. (Pubitemid 26356458)
32. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS (1994) Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269, 8445-8454. (Pubitemid 24200266)
33. Young WS, 3rd (1986) Periventricular hypothalamic cells in the rat brain contain insulin mRNA. Neuropeptides 8, 93-97.
34. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101, 757-770. (Pubitemid 46633313)
35. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842.
36. Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22, 246-260.
37. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao WQ, Ferreira ST, Klein WL(2009) Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 106, 1971-1976.
38. Baskin DG, Schwartz MW, Sipols AJ, D'Alessio DA, Goldstein BJ, White MF (1994) Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 134, 1952-1955. (Pubitemid 24110760)
39. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E,Wilden PA, Cahill DA, Goldstein BJ, White MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77. (Pubitemid 21896701)
40. Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, Sbraccia P, Borboni P, Lauro R, Sesti G (2000) Insulin receptor substrate (IRS) transduction system: Distinct and overlapping signaling potential. Diabetes Metab Res Rev 16, 434-441. (Pubitemid 32066549)
41. Johnston AM, Pirola L, Van Obberghen E (2003) Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett 546, 32-36. (Pubitemid 36789763)
42. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122, 1316-1338.
43. Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson PA, Wesslau C (1999) Insulin signaling and action in fat cells: Associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 892, 119-126.
44. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, Lane WS, Pierce JH, White MF (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173-177.
45. Lavan BE, Lane WS, Lienhard GE (1997) The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272, 11439-11443. (Pubitemid 27184151)
46. Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P, Zierath JR (2002) Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45, 1697-1702. (Pubitemid 35478139)
47. Li C, Zhao R, Gao K,Wei Z, YinMY, Lau LT, Chui D, Hoi Yu AC (2011) Astrocytes: Implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 8, 67-80.
48. Bulat M, Klarica M (2011) Recent insights into a new hydrodynamics of the cerebrospinal fluid. Brain Res Rev 65, 99-112.
49. BrantAM,Jess TJ, Milligan G, Brown CM, GouldGW(1993) Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem Biophys Res Commun 192, 1297-1302. (Pubitemid 23218553)
50. Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain-an immunohistochemical study. J Chem Neuroanat 28, 117-136. (Pubitemid 39336524)
51. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96, 1005-1015.
52. Duelli R, Schrock H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12, 737-743.
53. Salkovic-Petrisic M, Lackovic Z (2003) Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes. J Neural Transm 110, 15-29. (Pubitemid 36135552)
54. Gotz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9, 532-544. (Pubitemid 351873467)
55. McGowan E, Eriksen J, Hutton M (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 22, 281-289.
56. Oikawa N, Kimura N, Yanagisawa K (2010) Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition. Brain Res 1315, 137-149.
57. Kimura N, Tanemura K, Nakamura S, Takashima A, Ono F, Sakakibara I, Ishii Y, Kyuwa S, Yoshikawa Y (2003) Agerelated changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun 310, 303-311. (Pubitemid 37163664)
58. Nakamura S, Nakayama H, Goto N, Ono F, Sakakibara I, Yoshikawa Y (1998) Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys. J Med Primatol 27, 244-252. (Pubitemid 128521592)
59. Grondin R, Zhang Z, Gerhardt GA, Gash DM (2000) Dopaminergic therapy improves upper limb motor performance in aged rhesus monkeys. Ann Neurol 48, 250-253. (Pubitemid 30617045)